Infection Control for the Human and Animal Health Market Research Report Data by Product (Disinfection Products [Liquid Disinfectants, Disinfectant Wipes, Disinfectant Sprays, and Others], Personal Protective Equipment (PPE) [Gloves, Masks, Gowns, Protect

Infection Control for the Human and Animal Health Market Research Report Data by Product (Disinfection Products [Liquid Disinfectants, Disinfectant Wipes, Disinfectant Sprays, and Others], Personal Protective Equipment (PPE) [Gloves, Masks, Gowns, Protective Eyewear, and Others], and Sterilization Equipment [Heat Sterilization Equipment, Low-temperature Sterilization Equipment, Radiation Sterilization Equipment, and Filtration Sterilization Equipment]), by Infection Type (Viral, Bacterial, Parasitic, and Fungal Infections), by End Us (Human Healthcare Facilities and Animal Healthcare facilities)- Industry Forecast to 2032

The industry for infection control in the human and animal health market is expected to expand at a compound annual growth rate (CAGR) of 8.16% between 2023 and 2032, from USD 9.56 billion in 2023 to USD 20.95 billion.

One major factor driving the infection control market for human and animal health is the rising incidence of infectious diseases. The prevalence of several infectious diseases has noticeably increased globally in recent years, which has raised demand for infection control techniques and solutions.

One of the main factors driving infection control in the human and animal health market is the increased knowledge of infection control practices. The experiences of recent pandemics and global health crises have increased public and professional awareness of the significance of infection prevention. An educated public and a healthcare community are benefits of increased media coverage, government initiatives, and educational campaigns. Both the general public and medical professionals are realizing how important it is to stop the transmission of infectious diseases by using sterilizing equipment, personal protection equipment (PPE), and disinfection solutions. Advanced and efficient infection control solutions are in high demand as infection control measures are being stressed more and more in a variety of contexts, such as public areas, hospitals, and clinics.

Insights on market segments
The Personal Protective Equipment (PPE), Sterilization Equipment, and Disinfection Products segments of the Infection Control for Human and Animal Health Market are based on product.

The market has been divided into segments according to the kind of infection: bacterial, fungal, viral, and parasitic.

The market is divided into two segments based on the end user: human healthcare facilities and animal healthcare facilities.

Localized Perspectives
Due to the region's expanding sophisticated healthcare infrastructure, strict laws, high awareness of infection control precautions, and growing rate of surgical procedures, North America held the biggest market share in 2022—more than 33.75%. In orthopedic surgery, personal protective equipment (PPE) is often used to avoid infections in both patients and healthcare staff. The 2021 annual report from the American Joint Replacement Registry states that 2,244,587 hip and knee surgeries were carried out.

Due to an increase in infection incidence throughout Europe, infection control for human and animal health is expected to develop significantly during the projection year, 2022–2023. The demand for sophisticated preventative measures and growing awareness of infectious illnesses are driving a strong boom in the European market for infection control, which includes both human and animal health. On June 26, 2023, the World Health Organization said that there has been a rise in confirmed instances of E-11 infection in neonates and babies, with severe morbidity and mortality, in Croatia, Italy, Spain, Sweden, and the United Kingdom of Great Britain and Northern Ireland.

The market for infection control in both human and animal health is vibrant and diverse in the Asia-Pacific area. The need for efficient infection prevention and control strategies is developing as a result of the world's population expanding quickly, growing urbanization, and greater consciousness of healthcare standards. The United Nations Population Fund (UNFPA) estimates that 4.3 billion people, or 60% of the world's population, live in Asia and the Pacific.

Principal Players
Advanced Sterilization Products (US), STERIS plc (Ireland), Getinge AB (Sweden), Virox Technologies, Inc. (Canada), 3M (US), Zoetis Animal Healthcare (US), PeproTech Sciences Inc. (Canada), Neogen Corporation (US), Cardinal Health (US), and Stryker (US) are important players in the infection control market for human and animal health.